The pre-configured solution offers a full range of functionality for teams engaged in commercial operations within the Pharmaceutical, Biotech, and Medical Device industries
BOSTON, Oct. 14, 2021 /PRNewswire/ — Creatio, a global software company that provides a leading no-code platform for process management and CRM, today announced its long-term US-based partner Keen360 has launched a vertical solution Keen Life Sciences on the Creatio Marketplace. The pre-configured application offers enterprise-caliber functionality and security, extending the no-code Creatio platform capabilities to allow professionals engaged in commercial operations in the life sciences industry to power-up their day-to-day operations.
Keen Life Sciences is well suited for both well-established companies that are relying on mature commercial teams and rapidly-growing ventures that are emerging from clinical trials and launching their commercial teams. The solution offers the full range of functionality usually found in the complex and expensive applications that are built on the SFDC platform. Keen Life Sciences can either substitute or complement those well-known SFDC-based applications.
"We have been working in Life Sciences for over a decade, helping our clients achieve commercial excellence. And what we have seen almost without exception in Pharma, Biotech, and Medical Devices—whether for emerging ventures or global enterprises—is low adoption, high costs, and high dissatisfaction from the field force to the home office with the well-known CRM products for this industry. And when we found Creatio with its no-code/low-code BPM engine in 2019, we suddenly saw that we could deliver a product to satisfy the demand for better CRM in Life Sciences," said David Lashar, Partner at Keen 360. "Through continuous iteration that Creatio makes easy, we're now excited to share that our Keen Life Sciences product for the Creatio platform is ready to support not just a classic team of medical sales representatives but also the teams for managing key accounts, launching new products, responding to medical inquiries, running sales operations, and monitoring for compliance," he added.
Key Keen Life Sciences features:
HCO & HCP profiles: capture and maintain the range of domain-specific information about your HCOs and HCPs.
Affiliations & relationships: capture and maintain the complex web of organizational affiliations (GPOs, IDNs, etc).
Territories & alignment: create and maintain multi-tier models for the sales organization, encompassing both geography-based and manually-based (i.e., ad hoc or override) assignments.
Targeting plans & attainment: assign targets, then track attainment thereof for each level of the sales organization.
Detailing, surveys, & samples: enable field reps to plan, perform, and document their HCP interactions related to detailing, surveys, and samples… including e-signature.
Approvals & compliance: enable closed-loop approvals for any documents, assets, or policies requiring reviews and approvals from a distributed functional team (i.e., legal, marketing, medical, etc).
Mobility & portals: download the free Creatio app to have access to information and assets on mobile devices.
More information about the solution can be found on the Creatio Marketplace.
Media contact:
Vera Mayuk
321347@email4pr.com
+1 617 765 7997
View original content:https://www.prnewswire.com/news-releases/keen360-released-keen-life-sciences-for-pharma-biotech–medical-device-industries-to-extend-creatios-no-code-platform-capabilities-301399772.html
SOURCE Creatio
‘As long as all service staff are doing their job and getting paid an hourly wage, there is no reason to tip anyone.’
The suit says the "scalding" hot coffee spilled onto her in a car in the drive-thru of a Brockton, Massachusetts location – and that what happened next made matters worse.
Retail isn't alone in feeling the effects of the worker shortage. Here's another.
Personal-finance pundits love to debate safe withdrawal rates—the amount a retiree can withdraw each year from a portfolio without depleting it too quickly. On the income side, do you envision a traditional retirement—that is, stopping work entirely—or would you like to taper down to part-time, perhaps taking on a new job or starting a small business? It seemed like an odd choice for a high-net-worth retiree.
(Bloomberg) — Johnson & Johnson is turning to bankruptcy court in a controversial attempt to resolve billions of dollars in legal liabilities tied to its talc products, placing a new subsidiary holding the claims into Chapter 11 protection. Most Read from BloombergOut-of-Practice Airline Pilots Are Making Errors Back in the AirThe World’s Rich and Powerful Are Stashing $500 Billion in This Tax HavenWhy Buying a Second or Even Third Home Is Becoming More Popular Than EverWhat Comes After GE’s 12
After Thursday’s pullback, it’s been a bearish start to the day. A move back through to $0.000029 levels would signal a breakout day ahead, however.
Employees earlier this week rejected a new, six-year collective bargaining agreement, which included immediate pay raises of 5% to 6%.
President Biden has discussed the latest trends in retail fuel prices with representatives of the U.S. oil industry
District judge in Fort Worth, Texas, granted a restraining order in favor of employees who are suing the airline over the mandate.
(Bloomberg) — The largest U.S. natural gas driller is using the global energy crisis to renew his call for more investment in domestic infrastructure such as pipelines, which he says will enable increased exports and ease shortages.Most Read from BloombergOut-of-Practice Airline Pilots Are Making Errors Back in the AirThe World’s Rich and Powerful Are Stashing $500 Billion in This Tax HavenWhat Comes After GE’s 129 Years of Greenhouse GasWhy Buying a Second or Even Third Home Is Becoming More P
Investing in dividend stocks can be an excellent way to generate passive income. Companies that pay dividends tend to be more mature, profit-generating operations that have established lines of business and a loyal base of customers. One such company with a long history of profit generation and dividend payouts is Coca-Cola (NYSE: KO).
A longtime Toyota supplier, Nippon Steel, alleges the car maker and a Chinese supplier, Baoshan Iron & Steel, infringed on its patent on material used in steel sheets that make up Toyota engines.
Sherwin-Williams has quietly added a 4% 'supply chain charge' to its paint. It's the latest business to hide a price hike with extra fees.
New data shows the U.S. now leads the world in Bitcoin Mining followed by Kazakhstan, Russia and Canada. Here's what it might mean.
Lightspeed Commerce Inc. (NYSE: LSPD) (TSX: LSPD), the one-stop commerce platform for merchants around the world to simplify, scale, and create exceptional customer experiences, today announced the launch of the all-new Lightspeed Restaurant, a unified hospitality commerce and point-of-sale (POS) platform.
Being a great investor sometimes involves making assumptions about the future of technology, so watch these two companies closely.
Yahoo Finance's Anjalee Khemlani talks about the upcoming FDA vote on recommendations for the Johnson & Johnson vaccine.
Yahoo Finance’s Emily McCormick breaks down concerns of Boeing’s 787 Dreamliner and the impact of this new concern for Boeing.
Rob Thummel, Portfolio Manager at Tortoise, joins Yahoo Finance to discuss the outlook on natural gas, opportunity in the energy sector, and gas prices.
The Nord Stream 2 pipeline is completed and ready to pump Russian gas to Europe, but nothing is flowing yet because it is still awaiting clearance from Germany's energy regulator. Europe's most controversial energy project, which is led by Russian gas giant Gazprom, has faced resistance from the United States and Ukraine among others. A move by the German regulator last week to ask the pipeline operator, Swiss-based Nord Stream 2 AG, for assurances it will not break competition rules suggests it could take several more months before the 1,200 km pipeline gets the green light.

source

Leave a Reply